Post-Marketing Surveillance of Vliwazell® Prowound Dressing
NCT ID: NCT07316556
Last Updated: 2026-01-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
208 participants
OBSERVATIONAL
2024-03-11
2027-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Post Market Clinical Follow-up Investigation to Evaluate Performance and Safety on Pressure Ulcers, PU, When Using Exufiber as Intended
NCT02224404
A Multicenter, Post Marketing Clinical Follow up (PMCF) Investigation to Evaluate the Performance and Safety of a Soft Silicone Foam Dressing and to Evaluate the Performance of Standard Care in Exuding Venous Leg Ulcers
NCT02167815
AQUACEL® Ag+ Extra™ vs Cutimed® Sorbact®
NCT07308678
Clinical Study of Moisture Sensor Dressing Used for Exuding Wounds
NCT04890769
Assessment of Efficacy & Tolerance of Urgo 310 3166 Dressing in Local Venous or Mixed Leg Ulcers
NCT03126396
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Vliwazell® Pro has high absorbent capacity and reduces the need for frequent dressing changes due to saturation, allowing the wound to remain undisturbed for longer periods. The outer layer is covered with a blue non-woven fabric that shields the patient's clothing and bed linen.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Superficial acute and chronic wounds with moderate to very high amounts of exudate and that are superficial, in:
* arterial and venous ulcers
* diabetic ulcers
* pressure ulcers
* post-traumatic wounds
* post-operative wounds healing by secondary intention
* skin graft donor sites
* oncological wounds
* ulcerating tumors
* wounds at risk of infection
* superficial 2nd degree burns
* lymphatic wounds
2. As secondary dressing on laparotomy wounds and fistulas or for deep wounds when used with appropriate wound filler
3. Patient has full legal capacity
4. Patient is able to understand and provide information
5. Patient has signed the written Informed Consent Form
Exclusion Criteria
2. Patient with contraindication:
* Known allergy and/or hypersensitivity to any of the product components.
* Not for use in tunnel-forming wound pockets, as the product may expand considerably with the absorption of wound exudate.
* Not for use on dry wounds.
3. Pregnant or lactating women
4. Patients participating in another clinical trial at the time of inclusion
5. Patient not covered by health insurance/social security
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lohmann & Rauscher
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thomas Eberlain, Dr
Role: PRINCIPAL_INVESTIGATOR
Lohmann & Rauscher
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Wundmanagement
Aachen, , Germany
MVZ Hausärzte
Brüggen, , Germany
ORGAMed
Dortmund, , Germany
Hautklinik
Erlangen, , Germany
Krankenhaus Tabea
Hamburg, , Germany
WKM Rösner Mönchengladbach
Mönchengladbach, , Germany
Gesundheitsmanager, Inh. Christine Bertram
Waidhaus, , Germany
WKM Rösner Willich
Willich, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.